Mar. 23 -- WEDNESDAY, Feb. 6 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first generic equivalents of Fosamax (alendronate sodium), Merck & Co.'s osteoporosis drug. In a ...
DEAR DR. ROACH: I’m a 65-year-old, overweight white woman. I recently had a DEXA scan, and based on the results, my general physician prescribed Fosamax for osteopenia. The first dose created a ...
Fosamax is a brand name of the generic drug alendronate. It helps treat osteoporosis due to menopause or steroid use. It works by altering bone formation and the breakdown of the bones in the body.
The U.S. Court of Appeals for the Federal Circuit invalidated on Friday the patent for the once-a-week version of Merck's blockbuster osteoporosis drug Fosamax. Under the ruling, generic competition ...
NEW YORK (Reuters) - Jurors heard sharply different closing arguments on Wednesday in a trial over whether or not Merck & Co's Fosamax drug treatment for osteoporosis caused a Florida woman's jaw ...
TRENTON, N.J. -- A federal court invalidated the patent on Friday for Merck & Co.'s second-largest selling drug, the blockbuster osteoporosis treatment Fosamax, in a decision that offers millions of ...
Due to its marked efficacy in the prevention of bone loss in susceptible populations, alendronate (generic name of BIS) had been proposed as a useful agent to prevent alveolar bone loss. [22] One ...
NEW YORK, Sept 9 (Reuters) - A Manhattan federal judge has rejected Merck & Co's effort to dismiss 24 cases alleging that its Fosamax drug treatment for osteoporosis causes jaw damage. In an opinion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results